Abstract
YARS2 encodes the mitochondrial tyrosyl-tRNA synthetase that catalyzes the covalent binding of tyrosine to its cognate mt-tRNA. Mutations in YARS2 have been identified in patients with myopathy, lactic acidosis, and sideroblastic anemia type 2 (MLASA2). We report here on two siblings with a novel mutation and a review of literature. The older patient presented at 2 months with marked anemia and lactic acidemia. He required periodic blood transfusions until 14 months of age. Cognitive and motor development was normal. His younger sister was diagnosed at birth, presenting with anemia and lactic acidosis at 1 month of age requiring periodical transfusions. She is now 14 months old and doing well. For both our patients, there was no clinical evidence of muscle involvement. We found a new homozygous mutation in YARS2, located in the α-anticodon-binding (αACB) domain, involved in the interaction with the anticodon of the cognate mt-tRNATyr.
Our study confirms that MLASA must be considered in patients with congenital sideroblastic anemia and underlines the importance of early diagnosis and supportive therapy in order to prevent severe complications. Clinical severity is variable among YARS2-reported patients: our review of the literature suggests a possible phenotype-genotype correlation, although this should be confirmed in a larger population.
Keywords
Competing interests: None declared
Author contributed equally with all other contributors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bonnefond L, Frugier M, Touzé E et al (2007) Crystal structure of human mitochondrial tyrosyl-tRNA synthetase reveals common and idiosyncratic features. Structure 15:1505–1516
Burrage LC, Tang S, Wang J et al (2014) Mitochondrial myopathy, lactic acidosis, and sideroblastic anemia (MLASA) plus associated with a novel de novo mutation (m.8969G>A) in the mitochondrial encoded ATP6 gene. Mol Genet Metab 14:S1096–S7192
Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308
Diodato D, Ghezzi D, Tiranti V (2014) The Mitochondrial Aminoacyl tRNA Synthetases: genes and syndromes. Int J Cell Biol 2014:787956
Edwards H, Schimmel P (1987) An E. coli aminoacyl-tRNA synthetase can substitute for yeast mitochondrial enzyme function in vivo. Cell 51:6439–6649
Fernandez-Vizarra E, Berardinelli A, Valente L, Tiranti V, Zeviani M (2007) Nonsense mutation in pseudouridylate synthase 1 (PUS1) in two brothers affected by myopathy, lactic acidosis and sideroblastic anaemia (MLASA). J Med Genet 44:173–180
Fujiwara T, Harigae H (2013) Pathophysiology and genetic mutations in congenital sideroblastic anemia. Pediatr Int 55:675–679
Hallmann K, Zsurka G, Moskau-Hartmann S et al (2014) A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy. Neurology 83:2183–2187
Konovalova S, Tyynismaa H (2013) Mitochondrial aminoacyl-tRNA synthetases in human disease. Mol Genet Metab 108:206–211
Nakajima J, Eminoglu TF, Vatansever G et al (2014) A novel homozygous YARS2 mutation causes severe myopathy, lactic acidosis, and sideroblastic anemia 2. J Hum Genet 59:229–232
Riley LG, Cooper S, Hickey P et al (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia-MLASA syndrome. Am J Hum Genet 87:52–59
Riley LG, Menezes MJ, Rudinger-Thirion J et al (2013) Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. Orphanet J Rare Dis 8:193
Rötig A (2011) Human diseases with impaired mitochondrial protein synthesis. Biochim Biophys Acta 1807:1198–1205
Sasarman F, Nishimura T, Thiffault I, Shoubridge EA (2012) A novel mutation in YARS2 causes myopathy with lactic acidosis and sideroblastic anemia. Hum Mutat 33:1201–1206
Schwartzentruber J, Buhas D, Majewski J et al (2014) Mutation in The Nuclear-Encoded Mitochondrial Isoleucyl-tRNA Synthetase IARS2 in Patients with Cataracts, Growth Hormone Deficiency with Short Stature, Partial Sensorineural Deafness, and Peripheral Neuropathy or with Leigh Syndrome. Hum Mutat 35:1285–1289
Shahni R, Wedatilake Y, Cleary MA, Lindley KJ, Sibson KR, Rahman S (2013) A distinct mitochondrial myopathy, lactic acidosis and sideroblastic anemia (MLASA) phenotype associates with YARS2 mutations. Am J Med Genet 161:2334–2338
Yaremchuk A, Kriklivyi I, Tukalo M, Cusack S (2002) Class I tyrosyl-tRNA synthetase has a class II mode of cognate tRNA recognition. EMBO J 21:3829–3840
Acknowledgments
This work was supported by Fondazione Pierfranco e Luisa Mariani (CM23), Fondazione Telethon (grant GGP11011), Cell line and DNA Bank of Genetic Movement Disorders and Mitochondrial Disesases of Telethon Network of Genetics Biobanks (grant GTB12001) and the Italian Association of Mitochondrial Disease Patients and Families (Mitocon ONLUS).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Additional information
Communicated by: Gregory M. Pastores, MD
Appendices
Take-Home Message
MLASA must be considered in patients with congenital sideroblastic anemia: early diagnosis and supportive therapy may be important to prevent severe complications.
Compliance with Ethic Guidelines
Conflict of Interest statements
Anna Ardissone, Eleonora Lamantea, Jade Quartararo, Cristina Dallabona, Franco Carrara, Isabella Moroni, Claudia Donnini, Barbara Garavaglia, Massimo Zeviani, and Graziella Uziel declare that they have no conflict of interest.
Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all patients for being included in the study.
Animal Rights
This article does not contain any studies with animal subjects performed by the any of the authors.
Contributions of Individual Authors
AA, IM, and GU evaluated the patients and wrote the case report. FC performed biochemical and molecular analyses. EL monitored biochemical and genetic analyses. JQ and CDa performed experiments in yeast model. CDo coordinated the yeast studies. AA and EL wrote the manuscript; MZ, BG, and GU critically revised the manuscript for important intellectual content. All authors read and approved the manuscript.
Rights and permissions
Copyright information
© 2014 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ardissone, A. et al. (2014). A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature. In: Zschocke, J., Baumgartner, M., Morava, E., Patterson, M., Rahman, S., Peters, V. (eds) JIMD Reports, Volume 20. JIMD Reports, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2014_397
Download citation
DOI: https://doi.org/10.1007/8904_2014_397
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-46699-5
Online ISBN: 978-3-662-46700-8
eBook Packages: MedicineMedicine (R0)